13th week of 2013 patent applcation highlights part 40 |
Patent application number | Title | Published |
20130078141 | RADIATION STERILIZATION OF MEDICAL DEVICES - A method for medical device sterilization comprises staggering a stack of packages so that a back surface of each package partially overlaps a front surface of another of the packages. Each package contains a medical device. The stack of packages are positioned so that the front surfaces of the packages face toward a radiation source. The packages are then exposed to radiation. | 2013-03-28 |
20130078142 | Method and Apparatus for Sterilization of Medical Instruments and Devices by Ultraviolet Sterilization - An object is sterilized with ultraviolet-C (UV-C) radiation having a wavelength from about 235 nm to about 295 nm. An advantageous wavelength for the UV-C radiation is about 253.7 nm. The object is inserted into a container, which is then sealed. At least a portion of the container is substantially transparent to UV-C radiation over the wavelengths of interest. The container and object are placed into a UV-C irradiation device and are irradiated for an exposure time with UV-C radiation having a predetermined intensity. The exposure time is determined such that a predetermined portion of user-specified pathogens disposed on the object is inactivated. Technical sterilization (99.9999% inactivation) can be attained with relatively short exposure times. The container can be a flexible pouch or a rigid kit. Suitable materials that are substantially transparent to UV-C radiation over the wavelengths of interest include quartz, borosilicate glass, cyclic olefin copolymer, and fluoropolymer. | 2013-03-28 |
20130078143 | HYDROGEN PEROXIDE VAPORIZER WITH HEATED DIFFUSER - The present invention provides an apparatus for decontaminating a region. The apparatus includes a housing that defines a chamber therein. The housing has an inlet and an outlet that communicate with the chamber. A blower circulates a carrier gas from the region, through the inlet of the housing, through the chamber and out through the outlet of the housing. An atomizer introduces an atomized mist of a fluid into the carrier gas circulated through the chamber. A diffuser is disposed relative to the outlet of the chamber for redirecting said carrier gas exiting said outlet of said chamber into a predetermined direction. The diffuser includes a heating element. | 2013-03-28 |
20130078144 | LIQUID COLLECTION CONTAINER AND EXTRACORPOREAL CIRCUIT - A liquid collection bag is used as a part of an extracorporeal circuit and is connected via a tube to a storage container containing a priming solution. The collection container collects the priming solution from the storage container by a pressure differential between the pressure inside the collection container and the pressure inside the storage container. The liquid collection container is a flexible bag body having a partition part dividing the inside of the bag body into a first space and a second space. In addition, a communication part communicates the first space with the second space. | 2013-03-28 |
20130078145 | SEMICONDUCTOR-BASED DETECTION AND DECONTAMINATION SYSTEM - A system for identifying and making quantitative determinations with respect to deposits on a portion of the system, determining that the deposit is a contaminant, and decontaminating at least the portion of the system is described. The system uses an embedded controller. It further includes an embedded sensing portion monitoring an atmosphere above the sensing portion. The sensing portion communicates with at least said controller and detects a quantity of the deposits. The sensing portion can be a film layer on a surface. The system also includes an embedded self-decontaminating portion. | 2013-03-28 |
20130078146 | SURFACE PLASMON RESONANCE FLUORESCENCE ANALYSIS DEVICE AND SURFACE PLASMON RESONANCE FLUORESCENCE ANALYSIS METHOD - A surface plasmon resonance fluorescence analysis device emits a light beam to a prism in which a metal film is formed on a prescribed surface while changing an angle of incidence relative to the metal film in a state in which the light beam is totally reflected, measures light generated on a surface of the metal film, determines an angle at which the light beam enters the metal film based on a change in intensity of the measured light, adjusts the emitting direction of the light beam so that the light beam enters the metal film at the determined angle of incidence, and measures fluorescence generated on the surface of the metal film in a state in which the light beam is emitted the adjusted direction. | 2013-03-28 |
20130078147 | LIQUID-TRANSPORT AND ANALYTICAL TEST DEVICE - A liquid-transport device has a liquid-tight support ( | 2013-03-28 |
20130078148 | NEAR FIELD-ENHANCED FLUORESCENCE SENSOR CHIP - A surface plasmon-field enhanced fluorescence spectroscopy [SPFS] sensor chip may include a transparent support, a metal thin film formed on one surface of the transparent support, a self-assembled monolayer [SAM] formed on a surface of the metal thin film, said surface not being in contact with the transparent support, a solid phase layer formed on a surface of the SAM and having a three-dimensional structure, said surface not being in contact with the metal thin film, and a ligand immobilized in the solid phase layer. A fluctuation ratio represented by the following formula is not less than 0% but not more than 30%: | 2013-03-28 |
20130078149 | CENTRIFUGE CONFIGURATIONS - Systems and methods are provided for sample processing. A device may be provided, capable of receiving the sample, and performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing multiple assays. The device may comprise one or more modules that may be capable of performing one or more of a sample preparation, sample assay, and detection step. The device may be capable of performing the steps using a small volume of sample. | 2013-03-28 |
20130078150 | GEL PARTICLE MEASUREMENT DEVICE - To measure a starting point of production of gel particles with high sensitivity in measurement of a target substance in a sample through a gelation reaction while minimizing light attenuation in a solvent in which a phenomenon occurs, provided is a gel particle measurement device including: a sample cuvet ( | 2013-03-28 |
20130078151 | LIQUID CRYSTAL GAS SENSOR CELL AND THE USE THEREOF - A gas sensor cell using a liquid crystal composite material is provided. The gas sensor cell has recovery capability and can be reused. Upon gas adsorption, the liquid crystal composite material has visually detectable color changes and changes in electrical properties to facilitate the measurement of gas concentration from low to high. | 2013-03-28 |
20130078152 | Device for Conditioning Process Gases for the Heat Treatment of Metallic Work Pieces in Industrial Furnaces - In a device for preparing process gases ( | 2013-03-28 |
20130078153 | BULKHEAD ASSEMBLY FOR VHP UNIT WITH REMOVABLE DIFFUSER - A system for decontaminating an enclosure that defines a region. The system includes a decontamination unit for generating a vaporized sterilant. The decontamination unit includes a housing that defines a chamber therein. An inlet and an outlet of the housing fluidly communicate with the chamber. A bulkhead assembly connects the decontamination unit to the enclosure. The bulkhead assembly includes a barrier assembly for sealing an opening of the enclosure. The membrane traverses the opening of the enclosure. A first port and a second port allow the carrier gas to flow through the membrane. A frame assembly seals the barrier assembly into the opening of the enclosure. An outlet conduit defines a flow path for conveying the carrier gas from the decontamination unit to the region of the enclosure. A return conduit defines a flow path for conveying the carrier gas from the enclosure to the decontamination unit. | 2013-03-28 |
20130078154 | SYSTEM FOR REFRACTORY LAYER MEASUREMENT - The present embodiments are directed toward a system for measuring a refractory layer of a gasifier. In one embodiment, the gasifier includes a first refractory layer disposed about a gasification chamber, a second refractory layer disposed about the first refractory layer, and a temperature sensor disposed between the first refractory layer and the second refractory layer. The temperature sensor may collect temperature data for use in determining a thickness of the first refractory layer. | 2013-03-28 |
20130078155 | Method and Device for Thermal Insulation of Micro-Reactors - A micro-fluidic device is described. The micro-fluidic device includes a semiconductor substrate; at least one micro-reactor in the semiconductor substrate; one or more micro-fluidic channels in the semiconductor substrate, connected to the at least one micro-reactor; a cover layer bonded to the semiconductor substrate for sealing the one or more micro-fluidic channels; and at least one through-substrate trench surrounding the at least one micro-reactor and the one or more micro-fluidic channels. | 2013-03-28 |
20130078156 | METHOD AND A DEVICE PERTAINING TO THE SERVICE NEED OF A FILTER IN A SCR-SYSTEM'S LIQUID SUPPLY DEVICE - Disclosed is a method pertaining to SCR systems for exhaust cleaning whereby liquid is supplied to a feed device via which it is supplied to a dosing unit at a consumption point of the SCR system. The method includes continuously determining cumulative amounts of liquid dosed via the dosing unit. Need for replacement or cleaning of a filter unit for said liquid is also determined on the basis of the cumulative amounts of liquid dosed. The method further includes dosing at least part of the liquid supplied via the feed device and feeding undosed liquid back in a return flow to enable it to be supplied again to the feed device. Also disclosed is a computer program product that includes code for a computer for implementing the disclosed method. | 2013-03-28 |
20130078157 | CONTINUOUS PROCESS FOR CONVERTING NATURAL GAS TO LIQUID HYDROCARBONS - A method comprising: providing an alkyl halide stream; contacting at least some of the alkyl halides with a coupling catalyst to form a product stream comprising higher hydrocarbons and hydrogen halide; contacting the product stream with a solid reactant to remove at least a portion of the hydrogen halide from the product stream; and reacting the solid reactant with a source of oxygen to generate a corresponding halogen. | 2013-03-28 |
20130078158 | FUEL GASIFICATION SYSTEM - A fuel gasification system including a gasification furnace including a fluidized bed formed by fluidizing reactant gas for gasifying fuel charged into gasification gas and flammable solid content, a combustion furnace for combustion of the flammable solid content into which the flammable solid content produced in the furnace is introduced together with bed material and that includes a fluidized bed formed by fluidizing reactant gas, a material separator such as hot cyclone that separates bed material from exhaust gas introduced from the combustion furnace, the separated bed material being fed through a downcomer to the gasification furnace, and a tar decomposing mechanism that heats the gasification gas produced in the furnace to decompose tar contained in the gasification gas. | 2013-03-28 |
20130078159 | SEPARATION OF CARBON DIOXIDE (CO2) FROM GAS MIXTURES BY CALCIUM BASED REACTION SEPARATION (CaRS-CO2) PROCESS - A reaction-based process developed for the selective removal of CO2 from a multicomponent gas mixture to provide a gaseous stream depleted in CO2 compared to the inlet CO2 concentration. The proposed process effects the separation of CO2 from a mixture of gases by its reaction with metal oxides. The Calcium based Reaction Separation for CO2 (CaRS-CO2) process consists of contacting CO2 laden gas with CaO in a reactor such that CaO captures CO2 by the formation of CaCO3. CaCO3 is regenerated by calcination leading to the formation of fresh CaO sorbent and the evolution of a concentrated stream of CO2. The “regenerated” CaO is then recycled for the further capture of CO2. This carbonation-calcination cycle forms the basis of the CaRS-CO2 process. This process also may use a mesoporous CaCO3 structure that attains >90% conversion over multiple carbonation and calcination cycles. | 2013-03-28 |
20130078160 | EXHAUST GAS-PURIFYING SYSTEM - An exhaust gas-purifying system for purifying exhaust gas discharged from a diesel engine includes a diesel oxidation catalyst through which the exhaust gas passes, a diesel particulate filter which includes a filter substrate and an active component supported by the filter substrate and exhibiting a catalytic activity for selective catalytic reduction and through which the exhaust gas having passed through the diesel oxidation catalyst penetrates, and an ammonia slip catalyst which includes a zeolite whose alkaline metal ions are partially exchanged with transition metal ions and through which the exhaust gas having penetrated the diesel particulate filter passes. | 2013-03-28 |
20130078161 | Rapid Heat Transfer Sterilization System For Surgical Instruments And Devices - A device and system is disclosed for sterilizing objects, commonly dental, medical, or veterinary instruments, by enhancing rapid hot air diffusion into an instrument container by means of a sliding cover overlaying an opening in the bottom of the instrument container when in the closed position and sliding horizontally to reveal the opening in the open position, allowing rapidly flowing hot air into the container for medical article sterilization. The sliding cover is moved to the open position just prior to the sterilization process by a mechanical means incorporated into the sterilizer with the sliding cover remaining in the open position through the completion of the sterilization process. Once the sterilization cycle is complete, the mechanical means is reversed, closing, sealing, and locking the sliding cover in place over the opening before the instrument container is removed from the sterilizer, ensuring continued medical instrumentation sterility inside the container. | 2013-03-28 |
20130078162 | COUNTERFEIT DETECTOR PEN - A counterfeit currency detector including a tubular body having a forward end and a rearward end, a contact assembly mounted at the forward end of the tubular body, and a counterfeit solution applicator mounted at the rearward end of the tubular body. The contact assembly includes an ultraviolet light source. | 2013-03-28 |
20130078163 | Deterministic High-Density Single-Cell Trap Array - A microfluidic platform for single-cell capture, stimulation, and imaging. It passively traps 4,000 single cells on a 4.5 mm | 2013-03-28 |
20130078164 | Device for Forming Drops in a Microfluidic Circuit - The invention relates to a device ( | 2013-03-28 |
20130078165 | SYSTEM FOR CARRYING OUT A SAMPLE PREPARATON - The invention relates to a system for carrying out a sample preparation for an analysis apparatus, in particular a chromatograph, comprising a sample vessel ( | 2013-03-28 |
20130078166 | METHOD FOR RECOVERING RHENIUM AND OTHER METALS FROM RHENIUM-BEARING MATERIALS - A method of recovering rhenium (Re) and other metals from Re-bearing materials in the form of ammonium perrhenate having at least the step of adding Re-bearing materials into a leaching slurry. Additionally, the method has the step of adjusting the pH of the slurry to obtain Re in soluble form in a metal salt solution and insoluble residues; filtering the metal salt solution to remove the insoluble residues; selectively precipitating Re from the metal salt solution; and filtering the Re precipitate from the metal salt solution to obtain a Re filtercake. The method further has the step of drying and formulating Re to produce Re sulfide product. | 2013-03-28 |
20130078167 | METHOD OF METALS RECOVERY FROM REFINERY RESIDUES - A method of recovering vanadium, nickel and molybdenum from heavy crude oil refinery residues comprises pyrolysis and combustion of the residues at temperatures up to 900° C. to produce an ash, converting the ash to an aqueous slurry comprising sodium hydroxide as leading agent and hydrogen peroxide as oxidizer, and extracting vanadium, nickel and molybdenum salts and oxides from the slurry. Extraction processes for the metals are disclosed. | 2013-03-28 |
20130078168 | SYSTEM AND METHOD FOR CARBON DIOXIDE SOLIDIFICATION - Disclosed is a method for solidifying carbon dioxide into carbonate, in which carbon dioxide is stably converted into and solidified into carbonate (mineral facies) by using steel slag or natural mineral by extracting an alkali component by supplying an ammonium salt solvent as an extraction solvent to raw slag and injecting carbon dioxide into an extract solution supplied to a carbonation reactor to produce carbonate precipitate from the extract solution through the induction of a conversion reaction of the carbon dioxide into the carbonate precipitate. Then after the above two step are performed at least one an acetic acid solvent is supplied as an extraction solvent to the raw slag so as to finally extract an alkali component; and carbon dioxide is injected into an extract solution to produce carbonate precipitate from the extract solution through the induction of a conversion reaction of the carbon dioxide into the carbonate precipitate. | 2013-03-28 |
20130078169 | REMOVAL OF MERCURY EMISSIONS - A system for removing gaseous pollutants, such as mercury from flue gases of a solid-fueled furnace ( | 2013-03-28 |
20130078170 | PHOSPHONIUM-BASED IONIC LIQUIDS AND THEIR USE IN THE CAPTURE OF POLLUTING GASES - An ionic liquid composition having the following chemical structural formula: | 2013-03-28 |
20130078171 | CARBON DIOXIDE CAPTURE METHOD, WITH OPTIMIZED ACID WASH SECTION - The carbon dioxide contained in combustion fumes is absorbed by an aqueous amine solution in section B | 2013-03-28 |
20130078172 | Layered Solid Sorbents For Carbon Dioxide Capture - A solid sorbent for the capture and the transport of carbon dioxide gas is provided having at least one first layer of a positively charged material that is polyethylenimine or poly(allylamine hydrochloride), that captures at least a portion of the gas, and at least one second layer of a negatively charged material that is polystyrenesulfonate or poly(acryclic acid), that transports the gas, wherein the second layer of material is in juxtaposition to, attached to, or crosslinked with the first layer for forming at least one bilayer, and a solid substrate support having a porous surface, wherein one or more of the bilayers is/are deposited on the surface of and/or within the solid substrate. A method of preparing and using the solid sorbent is provided. | 2013-03-28 |
20130078173 | COMBINED SLIP CATALYST AND HYDROCARBON EXOTHERM CATALYST - A catalyst comprising: (a) a first layer comprising an oxidizing catalyst having an effective PGM loading such that oxidation of hydrocarbons generates sufficient heat to regenerate soot, wherein said effective amount of PGM is greater than about 10 g/ft | 2013-03-28 |
20130078174 | DECOMPOSITION/ELIMINATION METHOD USING A PHOTOCATALYTIC MATERIAL - The present invention provides a new method for decomposing and/or removing hazardous substances using a photocatalytic material. The method of the present invention is sufficiently useful in fields requiring quick decomposition and/or removal of hazardous substances in gas and/or liquid phases. The decomposition method of the present invention using a photocatalytic material enables significantly efficient and rapid decomposition of hazardous substances in gas and/or liquid phases by causing a photocatalytic material to coexist with a dilute hydrogen peroxide solution. | 2013-03-28 |
20130078175 | HYDROXYLATION OF ICOSAHEDRAL BORON COMPOUNDS - The present invention relates to a synthetic method for producing a per-hydroxylated icosahedral boron compound via catalytic hydroxylation of icosahedral boron compound using a soft electrophile. | 2013-03-28 |
20130078176 | FLOW TUBE REACTOR FOR CONVERSION OF SILICON TETRACHLORIDE TO TRICHLOROSILANE - The invention relates to a method for converting silicon tetrachloride having hydrogen to trichlorosilane in a hydrodechlorination reactor, wherein the hydrodechlorination reactor is operated under pressure and comprises one or more reactor tubes which are made of a ceramic material. The invention further relates to the use of such a hydrodechlorination reactor as an integral component of a system for producing trichlorosilane from metallurgical silicon. | 2013-03-28 |
20130078177 | APPARATUS FOR MANUFACTURING CARBON NANOSTRUCTURE AND METHOD FOR MANUFACTURING CARBON NANOSTRUCTURE - An apparatus for manufacturing a carbon nanostructure and a method for manufacturing a carbon nanostructure that can achieve an increase in length and shape stabilization of the carbon nanostructure can be obtained. A manufacturing apparatus for a carbon nanostructure includes a catalyst member on which a carbon nanostructure is grown, a source gas supply unit and a source gas supply pipe, a coil, and a heater. The source gas supply unit and the source gas supply pipe supply the catalyst member with carbon for forming the carbon nanotube. The coil applies a gradient magnetic field (e.g., a cusped magnetic field indicated by magnetic flux line whose magnetic field strength gradually increases from one surface of the catalyst member to the other surface opposite to the one surface. The heater heats the catalyst member. | 2013-03-28 |
20130078178 | METHOD AND APPARATUS FOR FABRICATION OF CARBON NANOTUBES USING AN ELECTROSTATICALLY CHARGED SUBSTRATE AND LINER - A system for use in fabrication of carbon nanotubes (CNTs) includes a wafer having a circuitry and a plurality of CNT seed sites. The system also includes a base assembly configured to support the wafer. The system further includes a first tube disposed over the wafer and configured to surround the CNTs that form on the seed sites. The circuitry in the wafer is configured to conduct at least one static charge. The wafer includes a top surface having a plurality of CNT seed sites, each seed site coupled to the circuitry and configured to receive one of the at least one static charge. | 2013-03-28 |
20130078179 | METHOD FOR MAKING ALKALI ACTIVATED CARBON - A method for activating carbon via alkali activation processes includes the introduction of water vapor during the activation phase to control the formation of highly reactive by-products. The method includes heating the mixture of a carbon-containing first material and a alkali-containing second material, introducing water vapor at a first threshold temperature and stopping water vapor introduction at a second threshold temperature. The activated carbon material is suitable for carbon-based electrodes and for use in high energy density devices. | 2013-03-28 |
20130078180 | METHOD FOR PRODUCING HIGH CONCENTRATION AQUEOUS HF SOLUTIONS - Disclosed are methods used to remove HF from a fluorocarbon containing stream, thereby forming a final aqueous HF solution having both a high HF concentration and low dissolved organic content. | 2013-03-28 |
20130078181 | METHOD FOR PREPARING LTA-TYPE ZEOLITES USING A NOVEL STRUCTURE DIRECTING AGENT - This disclosure relates to LTA-type zeolites which are synthesized using tris[2-(isopropylamino)ethyl]amine as a structure directing agent. | 2013-03-28 |
20130078182 | Structural Variants of Antibodies for Improved Therapeutic Characteristics - Substituted humanized, chimeric or human anti-CD20 antibodies or antigen binding fragments and bispecific antibodies or fusion proteins comprising the substituted antibodies or antigen binding fragments are disclosed. They are useful for treatment of B-cell disorders, such as B-cell malignancies and autoimmune diseases, as well as GVHD, organ transplant rejection, and hemolytic anemia and cryoglobulinemia. Substitution of an aspartate residue at Kabat position 101 of CDR3 V | 2013-03-28 |
20130078183 | Multiple Signaling Pathways Induced by Hexavalent, Monospecific and Bispecific Antibodies for Enhanced Toxicity to B-Cell Lymphomas and Other Diseases - Disclosed herein are compositions and methods of use comprising hexavalent DNL complexes. Preferably, the complexes comprise anti-CD20 and/or anti-CD22 antibodies or fragments thereof. More preferably, the anti-CD20 antibody is veltuzumab and the anti-CD22 antibody is epratuzumab. Administration of the subject hexavalent DNL complexes induces apoptosis and cell death of target cells in diseases such as B-cell lymphomas or leukemias, autoimmune disease or immune dysfunction disease. In most preferred embodiments, the DNL complexes increase levels of phosphorylated p38 and PTEN, decrease levels of phosphorylated Lyn, Akt, ERK, IKKα/β and IκBα, increase expression of RKIP and Bax and decrease expression of Mcl-1, Bcl-xL, Bcl-2, and phospho-BAD in target cells. The subject DNL complexes show EC | 2013-03-28 |
20130078184 | FLUORINATED FRUCTOSE DERIVATIVES FOR PET IMAGING - The present invention is directed to fructose-based radiopharmaceuticals, pharmaceutical compositions comprising same, precursors and methods for preparing same, and methods of using same for diagnostic imaging of cancer cells and non-imaging tracer studies. | 2013-03-28 |
20130078185 | NITROIMIDAZOLE DERIVATIVES - The present invention provides novel compounds useful in the treatment and diagnosis of mycobacterial infections. Compounds of the present invention have enhanced biological properties as compared to the related known compounds. The present invention also provides a precursor compound useful in the synthesis of certain compounds of the invention, and a method to obtain these compounds using said precursor compound. Methods of treatment and diagnosis in which the compounds of the invention fmd use are also provided. | 2013-03-28 |
20130078186 | AZO COMPOUNDS REDUCING FORMATION AND TOXICITY OF AMYLOID BETA AGGREGATION INTERMEDIATES - The present invention relates to compounds suitable as modulators of protein misfolding and/or protein aggregation. The compounds are particularly suitable as inhibitors of amyloid aggregate formation and/or modulators of amyloid surface properties, and/or as activators of degradation or reduction of amyloid aggregates. | 2013-03-28 |
20130078187 | Method for Selecting Bacteria with Anti-Oxidant Action - The present invention relates to a method using | 2013-03-28 |
20130078188 | ACTIVATABLE CELL PENETRATING PEPTIDES WITH QUENCHED FLUOROPHORES - The invention provides compositions useful as molecular probes. In particular, the invention provides activatable cell penetrating peptides comprising a fluorescence donor and a fluorescence acceptor. Exemplary fluorescence donors and fluorescence acceptors include compounds derived from cyanine. Also provided are ratiometric, multispectral, and excitation lifetime imaging methods for detecting the molecular probes provided herein. | 2013-03-28 |
20130078190 | ANTI-MICROBIAL HAND TOWEL WITH TIME-DELAY CHROMATIC TRANSFER INDICATOR AND ABSORBENCY RATE DELAY - A disposable paper towel with an anti-microbial lotion and is provided with a chromatic transfer indicator which undergoes a delayed, visually perceptible color change at a predetermined time after the towel is wetted. An anti-microbial lotion on the towel increases water absorbency times (WAR) to further promote lotion transfer to the skin and increase lotion transfer effectiveness. | 2013-03-28 |
20130078191 | AEROSOL COMPOSITION - There is provided an aerosol composition which is high in fire safety and assures easy emulsification of an aqueous concentrate and a liquefied gas. The aerosol composition comprises 10 to 60 wt % of an aqueous concentrate and 40 to 90 wt % of a liquefied gas, and is obtained by emulsifying the aqueous concentrate and the liquefied gas, wherein the liquefied gas comprises a heavy liquefied gas (a) having a liquid density at 20° C. of from 1.15 to 1.30 (g/ml). | 2013-03-28 |
20130078192 | Use of neoflavonoids for flavor modification - The present invention relates primarily to the use of one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I) for flavor modification, in particular for altering or masking a bitter, astringent and/or metallic flavor impression of a bitter, astringent and/or metallic tasting substance and a corresponding method of flavor modification. The present invention further relates to certain mixtures and certain preparations fit for consumption containing one or a plurality of neoflavonoids of formula (I) and/or one or a plurality of physiologically acceptable salts of one or a plurality of neoflavonoids of formula (I). | 2013-03-28 |
20130078193 | Sweetener Compositions, Methods of Making Same and Consumables Containing Same - In one embodiment, the invention is to a sweetener composition comprising at least one sweetener and a pregelatinized starch, in particular to novel sweetener compositions that have a prolonged sweetener release rate and that provide a prolonged sweetening sensation to the consumer. The pregelatinized starch comprises particles having a plurality of pores having a specific average pore diameter. The sweetener is disposed in at least one of the pores. At least 50% of the particles has an average particle size of at least 50 microns. | 2013-03-28 |
20130078194 | COMPOSITIONS FOR DENTAL TREATMENT COMPRISING LIPOTEICHOIC ACIDS OR PARTS THEREOF LIKE MONO- OR POLYGLYCERPHOSPHATES - The present invention refers to compositions for the treatment or prophylaxis of infectious or inflammatory processes in the oral cavity (cavitas oris) including dental hygiene, the composition comprising lipoteichoic acids and glycerophosphate derivatives, preferably added into a dental hygiene product like toothpastes, toothgels, creams or rinsing fluids, the use of glycerophosphate derivatives as prophylaxis against bacterial infections of the oral cavity like dental caries, or the use of polyglycerophosphates for the production of a medicament for the treatment of or prophylaxis against bacterial infections of the oral cavity, like dental caries. | 2013-03-28 |
20130078195 | ADHESIVE DENTAL BLEACHING COMPOSITIONS CONTAINING POLYVINYLPYRROLIDONE - A dental bleaching composition comprises a dental bleaching agent and a polyvinylpyrrolidone thickening agent. The bleaching composition may include water, flavoring agents, a basic substance and desensitizing agents, as desired. Polyvinylpyrrolidone avoids acid etching and chelation of teeth that were problematic in bleaches using carbomer as a thickener. A delivery system for delivering the bleaching composition comprises the aforementioned dental bleaching composition in combination with a moisture-resistant barrier layer such as a dental tray or a flexible strip of material. | 2013-03-28 |
20130078196 | DENTAL STERILIZING WATER, METHOD FOR PRODUCING THE WATER, AND DEVICE FOR PRODUCING THE WATER - This aims to produce dental sterilizing water having not only a sterilizing action but also an action to break a bio-film. Provided is a sterilizing water producing device ( | 2013-03-28 |
20130078197 | THERAPEUTIC ORAL COMPOSITION - Disclosed are therapeutic oral compositions useful in the treatment of a variety of oral disorders, in which the composition can provide blockage of dentinal tubes, while at the same time provide antibacterial and anti-caries efficacy. The compositions include arginine in free or salt form, a mucoadhesive polymer, and at least one component selected from pyrophosphates, zinc salts, potassium salts, strontium salts, and mixtures thereof. | 2013-03-28 |
20130078198 | NOVEL USE - This invention relates to the use of sodium dodecylbenzene sulphonate (SDDBS) for helping to prevent or remove surface deposited stains from natural teeth and dental prostheses and oral care compositions comprising SDDBS for such use. | 2013-03-28 |
20130078199 | TOPICAL SUNSCREEN COMPOSITIONS - Substantially anhydrous compositions including at least 10% by weight of a C | 2013-03-28 |
20130078200 | TOPICAL SUNSCREEN COMPOSITIONS - Substantially anhydrous compositions including at least 10% by weight of a C | 2013-03-28 |
20130078201 | TOPICAL SUNSCREEN COMPOSITIONS - Substantially anhydrous compositions including at least 10% by weight of a C | 2013-03-28 |
20130078202 | INHIBITION OF THE FORMATION OF AGEs - The present invention relates to the use of an active substance that promotes the inhibition of the formation of AGEs, for preparing a composition to prevent and/or combat the reduction in elastic and plastic properties of tissues, and in particular of the skin, for inhibiting the formation of AGEs, or for preventing and/or combating glycation of proteins in the skin. The invention also relates to a method of screening such active substances. | 2013-03-28 |
20130078203 | CAROTENOID SUNSCREEN - The invention concerns methods of treating or preventing the effects of irradiation in a human or non-human animal using sarcinaxanthin and related compounds (particularly its glycosides) as well as photoprotective compositions and their use to prepare photoprotective or photoprotected products. | 2013-03-28 |
20130078204 | TOPICAL SUNSCREEN COMPOSITIONS - Substantially anhydrous compositions including at least 10% by weight of a C | 2013-03-28 |
20130078205 | Compound, Composition, and Method for Protecting Skin from High Energy Visible Light - A compound, composition, and method for the protection of skin from the harmful effects of radiation, and particularly the harmful effects of high energy visible (HEV) radiation, are disclosed. The compound is a melanin derivative that can be formulated into compositions containing the melanin derivative and a suitable carrier. The composition is topically applied to the skin to reduce the risk of photoaging and improve skin repair due to damage from radiation. | 2013-03-28 |
20130078206 | Capsule of salts for pedicure bath - A water-soluble capsule for use in a pedicure bath that comprises the following substances: Dead Sea salts, olive oil, sodium bicarbonate, citric salt, starch, and fragrance. A method of manufacturing the capsule that includes the following stages: The aforementioned substances are placed in a mixer and a little water is added until a pourable mixture is obtained; the mixture is poured into a mold; pressure is applied to the capsule while in the mold; the mixture is dried in the mold until a solid capsule is obtained. | 2013-03-28 |
20130078207 | Artificial Nail Composition, Nail Covering Agent, And Method For Forming Cover Film - A novel artificial nail composition (gel nail composition) is provided. The artificial nail composition is curable with ultraviolet rays to form an artificial nail, and includes an ultraviolet-curable resin and pearl powder dispersed in the ultraviolet-curable resin. | 2013-03-28 |
20130078208 | QUATERNARY DIALKANOLAMINE ESTERS - The invention relates to novel quaternary ammonium compounds of the esterquat type, to a method for the production thereof, and to the use thereof in formulations. | 2013-03-28 |
20130078209 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF COMPROMISED SKIN BARRIER FUNCTION - Compositions and methods of treating conditions of compromised skin barrier function are described. | 2013-03-28 |
20130078210 | CHITOSAN DERIVATIVES FOR INACTIVATION OF ENDOTOXINS AND SURFACE PROTECTION OF NANOPARTICLES - The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer. In addition, the present disclosure provides a nanoparticle structure comprising a derivative of chitosan and a dendrimer, as well as methods of utilizing the nanoparticle structure. | 2013-03-28 |
20130078211 | MURGANTIOL AS A STINK BUG SYNERGISTIC ATTRACTANT FOR USE OUTDOORS - Provided herein are uses of the Harlequin bug pheromone, murgantiol, alone or in a synergistic combination with at least one other stink bug attractant, such as methyl (2E,4E,6Z)-decatrienoate or methyl (2E,4Z)-decadienoate, or both, for attracting stink bugs such as the brown marmorated stink bug in outdoor settings. Stink bug traps comprising murgantiol, or synergistic compositions comprising murgantiol with at least one other stink bug attractant, and methods of using these compositions in traps outdoors are provided. Compositions comprising murgantiol are also described as synergistic combinations of murgantiol with at least one other stink bug attractant. | 2013-03-28 |
20130078212 | Double Stranded RNA Constructs to Control Ants - Disclosed are double stranded RNA constructs used to inhibit the expression of guanine nucleotide binding (3-subunit to induce mortality in ants classified in the Formicidae family. | 2013-03-28 |
20130078213 | THROMBOPOIETIN MIMETICS - Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative. | 2013-03-28 |
20130078214 | Compounds for the Treatment of Hepatitis C - The disclosure provides compounds of formula I, including pharmaceutically acceptable salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV. | 2013-03-28 |
20130078215 | USES OF SELECTIVE INHIBITORS OF HDAC8 FOR TREATMENT OF INFLAMMATORY CONDITIONS - Described herein are methods for treating a subject suffering from an inflammatory, autoimmune, or heteroimmune condition by administering to the subject a pharmaceutical composition containing a therapeutically effective amount of a compound that is a selective inhibitor of histone deacetylase 8. Also described herein are methods for decreasing secretion of pro-inflammatory cytokines by administering an HDAC8-selective inhibitor compound. Further described herein are methods for predicting responsiveness to treatments for inflammatory conditions. Methods for predicting efficacy of treatments for inflammatory conditions are also described. | 2013-03-28 |
20130078216 | LIVER TARGETING MOLECULES - The present invention relates to molecules that can be targeted to the liver. These liver targeting molecules (e.g.fusions and conjugates) comprise proteins, antibodies or antibody fragments such as immunoglobulin (antibody) single variable domains (dAbs) and also one or more additional molecules which it is desired to deliver to the liver such as interferons. The invention further relates to uses, formulations, compositions and devices comprising such liver targeting molecules. The invention also relates to immunoglobulin (antibody) single variable domains which bind to hepatocytes. | 2013-03-28 |
20130078217 | 2'-CHLOROACETYLENYL SUBSTITUTED NUCLEOSIDE DERIVATIVES - The present invention relates to 2′-chloroacetylenyl-substituted nucleoside derivatives of the general formula (I): | 2013-03-28 |
20130078218 | HEPATITIS C THERAPIES - The invention provides methods for treating hepatitis C viral infections and related viral infections, as well as compounds and compositions that are useful for treating such infections. | 2013-03-28 |
20130078219 | GENETICALLY MODIFIED PARAMYXOVIRUS FOR TREATMENT OF TUMOR DISEASES - The present invention relates to a genetically modified Paramyxovirus, a pharmaceutical composition comprising this paramyxovirus, the use of a genetically modified Paramyxovirus for the therapeutic and/or prophylactic treatment of a tumor disease, and a method for the production of a pharmaceutical composition for the therapeutic or prophylactic treatment of a tumor disease. | 2013-03-28 |
20130078220 | DOPAMINERGIC NEURONAL SURVIVAL-PROMOTING FACTORS AND USES THEREOF - In general, the invention features substantially purified MANF and substantially purified nucleic acids encoding the same. The invention also features a pharmaceutical composition that includes MANF and a pharmaceutically-acceptable excipient, methods for treatment of a neurodegenerative disease, methods for improving dopaminergic neuronal survival during or following cell transplantation, methods for production of neurons for transplantation, and methods for identifying compounds that modulate or mimic MANF's biological activity. | 2013-03-28 |
20130078221 | MULTIPOTENT ADULT STEM CELL DERIVED FROM CANINE UMBILICAL CORD BLOOD, PLACENTA AND CANINE FETUS HEART, METHOD FOR PREPARING THE SAME AND CELLULAR THERAPEUTICS CONTAINING THE SAME - The present invention relates to multipotent adult stem cells derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart, and a method for preparing the same as well as a cellular therapeutic agent containing the same, more specifically, to a multipotent adult stem cell isolated by culturing an eukaryotic cell derived from canine umbilical cord blood, placental blood and blood sample from canine fetal heart in a FBS-containing medium and a method for preparing the same. Adult stem cells according to the present invention have characteristics highly similar to human mesenchymal stem cells as well as remarkable cell growth at the initial step compared to human UCB-derived mesenchymal stem cells so that the cells are useful to treat canine incurable diseases and difficult-to-cure diseases. Furthermore, multipotent adult stem cells are effective to treat musculoskeletal diseases and neural diseases. | 2013-03-28 |
20130078222 | Intervertebral Disc Nucleus Pulposus Stem Cell/Progenitor Cell, The Cultivation Method And Intended Use Thereof - Provided are intervertebral disk nucleus pulposus stem cells or progenitor cells that may be used for treatment of intervertebral disk disorders. An intervertebral disk nucleus pulposus cell is characterized by being isolated from the intervertebral disk nucleus pulposus of a vertebrate and is positive for at least one surface marker from among Tie2 and GD2. That is, the intervertebral disk nucleus pulposus stem cell is characterized by being at least Tie2-positive for the surface marker and) possesses a self-renewal ability as well as multipotency capable of differentiating into adipocytes, osteocytes, chondrocytes and neurons. Also provided is an intervertebral disk nucleus pulposus progenitor cell characterized by being at least Tie2-negative and GD2-positive for the surface marker and capable of differentiating into any of adipocytes, osteocytes, chondrocytes and neurons. | 2013-03-28 |
20130078223 | Method And Composition For Inducing Human Pluripotent Stem Cells - The present invention provides pluripotent stem cell like (PSCL) cells or clones, a culture medium therefore, and a supernatant thereof, and methods of making and using the same. | 2013-03-28 |
20130078224 | INDUCTION/MONITORING OF ARTERIOGENESIS USING SDF1 AND PDGFB OR INHIBITION OF PHD2 - The disclosure relates to the field of ischemia and how to increase tissue perfusion in ischemic tissue by cellular therapy. Specifically, the beneficial effects of myeloid (bone marrow-derived) cells with a particular arteriogenic gene expression profile are shown, and it is shown that increased arteriogenesis and perfusion is specifically due to the effects of combined PDGFB and SDF-1. The arteriogenic gene profile of the myeloid cells used for therapy can, for instance, be obtained by inhibition of PHD2. | 2013-03-28 |
20130078225 | Method for Modulating MicroRNA Content in Living Beings and the Use Thereof - The present invention relates to a method for modulating miRNA content in living beings and the use thereof, whereof the miRNAs are delivered initiatively and selectively by microparticles/MVs/exosomes to the circulatory system and target cells/tissues to perform various functions. The invention provides a novel combination of molecules that mediates the inter-cellular communication: the miRNAs secreted by cells through cellular MVs. Meanwhile, the present invention also provides a method for preparing cellular MVs entrapping certain miRNAs, and, according to the regulation and modification of gene expression in cells and tissues with the miRNA-entrapping cellular MVs, provides a novel method for modulating miRNA content in living beings, which is effective and adoptable to all cell types. | 2013-03-28 |
20130078226 | METHOD FOR RECONSTRUCTING IMMUNE FUNCTION USING PLURIPOTENT STEM CELLS - According to the present invention, there are provided a method for producing a human T cell, which comprises the steps of inducing an iPS cell from a human T cell, and differentiating the iPS cell into a T cell; a pharmaceutical composition comprising the T cell produced by the method; and a method for cell-based immunotherapy using the method. | 2013-03-28 |
20130078227 | EMBEDDED CHIMERIC PEPTIDE NUCLEIC ACIDS AND USES THEREOF - The present invention relates to an ecPNA having the general structure: | 2013-03-28 |
20130078228 | VITAMIN-CONTAINING NUTRITION INFUSION FOR ADMINISTRATION THROUGH PERIPHERAL VEIN - A nutrition infusion is provided for administration through a peripheral vein that contains a vitamin B group and vitamin C stably and includes two solutions of a sugar solution and an amino acid solution. In the nutrition infusion for administration through a peripheral vein, the sugar solution contains vitamin B1, vitamin B12, and pantothenic acid and has a pH of 4.7 to 5.5, and the amino acid solution contains vitamin B2, folic acid, vitamin C, and biotin and has a pH of 7.0 to 7.5. | 2013-03-28 |
20130078229 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER - The present invention is directed toward the delivery of toxic agents to pathogenic cells, particularly cancer cells. In some embodiments, the toxic agent is a human ribonuclease or similar agent that is toxic to cells. | 2013-03-28 |
20130078230 | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINOGMYELINASE DEFICIENCY - The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B. | 2013-03-28 |
20130078231 | DOSE ESCALATION ENZYME REPLACEMENT THERAPY FOR TREATING ACID SPHINOGMYELINASE DEFICIENCY - The invention relates to dose escalation enzyme replacement therapy using acid sphingomyelinase (ASM) for the treatment of human subjects having acid sphingomyelinase deficiency (ASMD), and, in particular, patients with non-neurological manifestations of Niemann-Pick Disease (NPD), and in certain embodiments, NPD type B. | 2013-03-28 |
20130078232 | COMPOSITIONS AND METHODS USEFUL FOR STABILIZING PROTEIN-CONTAINING FORMULATIONS - The invention relates to use of non-surfactant compounds including, for example, polyoxyethylene (POE) sorbitans and polyethylene glycols (PEGs), for stabilizing protein-containing formulations and for the prevention of aggregation of proteins in such formulations. | 2013-03-28 |
20130078233 | COMPOSITIONS AND METHODS USING SAME FOR TREATING AMYLOID-ASSOCIATED DISEASES - Compounds having one or more phenol moieties, derivatives thereof, compositions containing same and uses thereof for the treatment of amyloid-associated diseases are provided. | 2013-03-28 |
20130078234 | ANTI B7-H3 ANTIBODY - An antibody exhibiting antitumor activity that binds to B7-H3, a functional fragment of the antibody, a pharmaceutical composition that includes the antibody or the functional fragment, methods for making the antibody or the functional fragment, methods for treating a tumor using the antibody or the functional fragment, and polynucleotides encoding the antibody or the functional fragment. | 2013-03-28 |
20130078235 | NEUREGULIN BASED COMPOSITIONS AND USES THEREOF FOR PREVENTING, TREATING OR DELAYING THE MYOCARDIAL ISCHEMIA-REPERFUSION INJURY - The present invention elates to the applications of neuregulin in the preparation of drugs for preventing, treating or delaying the ischemia-reperfusion injury (IRI) in mammals, particularly in humans. In particular, the present invention provides the neuregulin based compositions and methods for preventing, treating or delaying the myocardial ischemia-reperfusion injury. Specifically, although it has been shown in cytological experiments, animal studies and clinical trials that neuregulin can improve the cytoskeleton structure of myocytes and cardiac function, it is still unknown whether neuregulin has effects on the myocardial ischemia-reperfusion injury. The present invention proves that neuregulin reduces the infarction size in the rat IRI model, which indicates that neuregulin can be used for preventing, treating or delaying the myocardial ischemia-reperfusion injury | 2013-03-28 |
20130078236 | Anti-CD28 humanized Antibodies - The invention relates to humanized antibodies directed against the human lymphocyte receptor CD28. When used in a monovalent form these antibodies are antagonists, i.e. capable of blocking of the CD28/B7 interaction, without activating CD28. These antibodies can be used in particular as therapeutic agents for blocking T cell activation through the CD28 receptor. | 2013-03-28 |
20130078237 | CD27L ANTIGEN BINDING PROTEINS - The present invention relates to CD27L antigen binding proteins, such an antibodies, polynucleotides encoding said CD27l antigen binding proteins, antibody drug conjugate compositions, and methods for diagnosing and treating diseases associated with CD27L expression. | 2013-03-28 |
20130078238 | Methods and Compositions for Treating Hepatitis with Anti-CD3 Immune Molecule Therapy - A method or composition comprising an anti-CD3 immune molecule for treatment of hepatitis in a subject. | 2013-03-28 |
20130078239 | HUMAN DIACYLGLYCEROL ACYLTRANSFERASE 2 (DGAT2) FAMILY MEMBERS AND USES THEREFOR - The present invention relates to compositions and methods for the diagnosis and treatment of obesity and related metabolic disorders. The invention provides isolated nucleic acids molecules, designated DGAT2 family member nucleic acid molecules, which encode diacylglycerol acyltransferase family members. The invention also provides recombinant expression vectors containing DGAT2 family member nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a DGAT2 family member gene has been introduced or disrupted. The invention still further provides isolated DGAT2 family member proteins, fusion proteins, antigenic peptides and anti-DGAT2 family member antibodies. Methods of use of the provided DGAT2 family member compositions for screening, diagnostic and therapeutic methods in connection with obesity disorders are also disclosed. | 2013-03-28 |
20130078240 | 4-1BB BINDING MOLECULES - The present disclosure provides isolated binding molecules that bind to human 4-1BB, nucleic acid molecules encoding an amino acid sequence of the binding molecules, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of making the binding molecules, pharmaceutical compositions containing the binding molecules, and methods of using the binding molecules or compositions. | 2013-03-28 |
20130078241 | ANTI-CD33 ANTIBODIES AND METHODS FOR TREATMENT OF ACUTE MYELOID LEUKEMIA USING THE SAME - The present invention relates to antibodies that bind CD33. More particularly, the invention relates to anti-CD33 antibodies, fragments and homologues of these antibodies, humanized and resurfaced versions of these antibodies, functional equivalents and improved versions of these antibodies, immunoconjugates and compositions comprising these antibodies, and the uses of same in diagnostic, research and therapeutic applications. The invention also relates to a polynucleotide encoding these antibodies, vectors comprising the polynucleotides, host cells transformed with polynucleotides and methods of producing these antibodies. | 2013-03-28 |